Stock info Coloplast | Filter  Basic-Info

Stock: Coloplast (Danmark large caps), ISIN: DK0010309657

Last Price 930.00 Max Price 990.80
Min Price 708.00 1 Year return -19.20
Sector Health Care Subsector Pharmaceuticals
Annual report 2015

Loading...

Contact info:Street: Holtedam 1 - 3Postbox: DK-3050City: HumlebaekCountry: DenmarkPhone: 45-49111111Website: www.cololas.comCEO: Lars RasmussenCFO: Anders LonningSkovgaard

Sector Review Coloplast

Loading...
Year Turnover Total sector Market share
2019 17,939 615,634 2.91 %
2020 18,544 638,070 2.91 %
2021 19,426 727,968 2.67 %
2022 22,579 787,273 2.87 %
2023 0 0 0.00 %

Advice Coloplast

No Records Found




News Coloplast

Analysts expect revenue increase Coloplast

Tomorrow the Danish Coloplast will report its past quarters results. For this year Coloplast 's (located in Humlebaek) revenue will be around 19.47 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly more than2020's...

Analysts expect over 2020 rising revenue Coloplast

Tomorrow Coloplast will publish its past quarters results. For this year the company from Humlebaek could earn a total revenue around 19.58 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly more than 2019's revenue...

Analysts expect over 2020 rising revenue Coloplast

Tomorrow the Danish Coloplast will publish its past quarter figures. For this year Coloplast's revenue will be around 19,48 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly more than 2018's revenue of 17,94 billion...

Analysts expect over 2019 rising revenue Coloplast

For this year Coloplast's revenue will be around 17,92 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly more than 2018's revenue of 16,45 billion Danish Krone. Historical revenues and results Coloplast plus estimates...

Analysts foresee more revenue Coloplast

Tomorrow Coloplast will publish it's past quarters results. For this year Coloplast's revenue will be around 17,93 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly more than 2018's revenue of 16,45 billion Danish...

Annual reports Coloplast

2017 2018 2019 2020 2021

Profile Coloplast

Coloplast

(DK0010309657)/ COLO B

Coloplast's head office is based in Humlebaek. The company mostly operates in the pharmaceutical sector. Lars Rasmussen is the company' CEO. Coloplast' CFO is Anders LonningSkovgaard. The past 10 years the (international) industry gained at around 75 percent. Over the past 5 years the sector is 147 percent higher.

The past year was a profitable year Coloplast investors

Over the past year the company' stock lost around 12 percent. Over the period 2011-2016 the stock rose a massive 194,13 percent. Coloplast's revenues between 2011 and 2015 were very volatile and moved between 2,65 billion euros and 3,34 billion euros. The net results between 2011 and 2015 were far from constant and fluctuated between 1,82 billion euros and 899 million euros.

The Danish company paid out dividends in the past 5 years. Coloplast's dividend return over the period 2011 - 2015 was around 40,8 percent per year.

At the end of 2015 Coloplast employed at around 9070 thousand people.

Coloplast financed with a quite low debt position

At the end of 2015 the Danish company had a balance sheet of 10,82 billion euros. 6,11 billion euros (56,49 percent of the total balance sheet) was financed by debt. At the end of 2015 the pharmaceutical company's stock was traded with a price/earnings-ratio 36. So the stock' value was 36 times the 2015' earnings per share. Based on the classical stock valuation theories the Danish stock can be seen as a value stock.

The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 115,21 billion euros. At the end of 2015 the Danish company had around 211 million stocks listed on the stock exchange(s).

At this page you find all Coloplast's financial reports. More information about Coloplast can be found it's website. .


Results Coloplast

Results
2015
2016
2017
2018
2019
2020
Revenue
13,909
14,681
15,528
16,449
17,939
18,544
Costs
13,010
11,538
11,731
12,604
14,066
14,347
Profit
899
3,143
3,797
3,845
3,873
4,197
Margin of profit
6.46
21.41
24.45
23.38
21.59
22.63
ROI
19.10
62.02
63.79
59.91
56.02
56.67

Balance Coloplast

Balance
2015
2016
2017
2018
2019
2020
Equity
4,706
5,068
5,952
6,418
6,913
7,406
Debt
6,111
5,939
6,098
5,351
5,819
6,093
Total assets
10,817
11,007
12,050
11,769
12,732
13,499
Solvency
43.51
46.04
49.39
54.53
54.30
54.86
Cash
1,400
1,035
629
607
669
585
Cashflow
3,337
3,028
3,251
4,375
4,357
4,759
Employees
9,706
0
0
0
0
Revenue per employee
1.43
0.0
0.0
0.0
0.0
Cashflow / Debt
0.55
0.51
0.53
0.82
0.75
0.78

Details Coloplast

Details
2016
2017
2018
2019
2020
Price
557.00
476.30
493.50
605.00
826.40
Eps
14.79
17.87
18.10
18.17
19.68
Price/earnings-ratio
37.66
26.65
27.27
33.30
47.26
Dividend
13.50
15.00
16.00
17.00
18.00
Dividend %
2.42 %
3.15 %
3.24 %
2.81 %
1.94 %
Payout %
0.91
0.84
0.88
0.94
0.91
Book value
26.16
30.65
33.02
35.56
38.04
Market to book
0.05
0.06
0.07
0.06
0.04
Cashflow per stock
15.63
16.74
22.51
22.41
24.45
Stocks
194
194
194
194
195
Market Cap
107.912.86
92.492.57
95.920.11
117.625.92
181.053.33

Dividend Coloplast


Price info Coloplast

Date
Price
22 Mar 2024
930.00
18 Mar 2024
930.60
15 Mar 2024
936.20
12 Mar 2024
976.00
11 Mar 2024
972.60
09 Mar 2024
972.60
07 Mar 2024
938.60
01 Mar 2024
915.60
29 Feb 2024
903.20
27 Feb 2024
918.60
22 Feb 2024
888.60
21 Feb 2024
885.60
20 Feb 2024
885.20
15 Feb 2024
878.60
14 Feb 2024
856.00
13 Feb 2024
879.80
09 Feb 2024
812.20
08 Feb 2024
812.20
07 Feb 2024
802.60
06 Feb 2024
792.80
05 Feb 2024
786.20
01 Feb 2024
797.60
31 Jan 2024
797.60
30 Jan 2024
775.80
27 Jan 2024
769.00
25 Jan 2024
769.40
24 Jan 2024
774.00
23 Jan 2024
778.20
16 Jan 2024
798.40
11 Jan 2024
784.00